Treatment options for autoimmune hepatitis: A systematic review of randomized controlled trials

Journal of Hepatology

Volumn 53, Issue 1, 2010, Pages 191-198

  Lamers, Mieke M H ^a   van Oijen, Martijn G H ^a   Pronk, Martine ^b   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune; Hepatitis; Systematic review

Indexed keywords

AZATHIOPRINE; INSULIN; PENICILLAMINE; PLACEBO; PREDNISOLONE; THYMOSTIMULIN; URSODEOXYCHOLIC ACID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ACNE; ARTHRALGIA; ASCITES; ASEPTIC NECROSIS; AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; BRONCHOPNEUMONIA; CATARACT; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CUSHINGOID SYNDROME; DIABETES MELLITUS; DRUG DOSE TITRATION; DUODENUM ULCER; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HISTOLOGY; HUMAN; HYPERTENSION; LEUKOPENIA; MAINTENANCE THERAPY; MEDICAL LITERATURE; MEDLINE; MELENA; MORTALITY; MYALGIA; MYOSITIS; OBESITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PANCYTOPENIA; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; REMISSION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VERTEBRA COLLAPSE; VERTEBRA MALFORMATION; HEPATITIS, AUTOIMMUNE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK;

AZATHIOPRINE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREDNISOLONE; PREDNISONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; RISK;

EID: 77953120859     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.037     Document Type: Review

References (25)

1. Czaja A.J. Current concepts in autoimmune hepatitis. Ann Hepatol 4 (2005) 6-24
2. Boberg K.M. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 6 (2002) 635-647
3. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
4. Krawitt E.L. Clinical features and management of autoimmune hepatitis. World J Gastroenterol 14 (2008) 3301-3305
5. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48 (2008) 169-176
6. Teufel A., Galle P.R., and Kanzler S. Update on autoimmune hepatitis. World J Gastroenterol 15 (2009) 1035-1041
7. Cook G.C., Mulligan R., and Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 40 (1971) 159-185
8. Soloway R.D., Summerskill W.H., Baggenstoss A.H., et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63 (1972) 820-833
9. Murray-Lyon I.M., Stern R.B., and Williams R. Controlled trial of prednisone and Azathioprine in active chronic hepatitis. Lancet 1 (1973) 735-737
10. Czaja A.J., and Freese D.K. Diagnosis and treatment of Autoimmune Hepatitis. Hepatology 36 (2002) 479-497
11. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
12. Stellon A.J., Hegarty J.E., Portmann B., and Williams R. Randomized controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis. Lancet 1 (1985) 668-670
13. Stellon A.J., Keating J.J., Johnson P.J., McFarlane I.G., and Williams R. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology 8 (1988) 781-784
14. Czaja A.J., Carpenter H.A., and Lindor K.D. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology 30 (1999) 1381-1386
15. Czaja A.J., Wang K.K., Shiels M.T., and Katzmann J.A. Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses. J Hepatol 17 (1993) 180-186
16. Hegarty J.E., Nouri Aria K.T., Eddleston A.L., and Williams R. Controlled trial of a thymic hormone extract (Thymostimulin) in 'autoimmune' chronic active hepatitis. Gut 25 (1984) 279-283
17. Tage-Jensen U., Schlichting P., Aldershvile J., et al. Azathioprine versus prednisone in non-alcoholic chronic liver disease (CLD). Relation to a serological classification. Liver 2 (1982) 95-103
18. Summerskill W.H.J., Korman G.K., Ammon H.V., and Baggenstoss A.H. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 16 (1975) 876-883
19. Stern R.B., Wilkinson S.P., Howorth P.J.N., and Williams R. Controlled trial of synthetic d-penicillamine and prednisone in maintenance therapy for active chronic hepatitis. Gut 18 (1977) 19-22
20. Manns M.P., and Strassburg C.P. Autoimmune hepatitis: clinical challenges. Gastroenterology 120 (2001) 1502-1517
21. Manns MP, Bahr MJ, Woynarowski M, et al. Budesonide 3 mg tid is superior to prednisone in combination with azathioprine in the treatment of autoimmune hepatitis. J Hepatol 2008;48:S369-70(S2) [Abstract].
22. Manns M.P., Woynarowski M., Kreisel W., et al. Budesonide 3 mg bid in combination with azathioprine as maintenance treatment of autoimmune hepatitis - final results of a large multicenter international trial. Hepatology 48 (2008) 376AS-377AS [Abstract]
23. Johnson P.J., McFarlane I.G., and Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333 (1995) 958-963
24. Czaja A.J. Treatment of Autoimmune Hepatitis. Semin Liver Dis 22 (2002) 365-378
25. Czaja A.J. Treatment challenges and investigational opportunities in Autoimmune Hepatitis. Hepatology 41 (2005) 207-215